pages:
-
A Phase II, Randomized, Placebo-Controlled, Double-Blind (Sponsor Open) Study of GSK1278863, a HIF-Prolyl Hydroxylase Inhibitor, to Reduce Ischemic Events in Patients
Undergoing Thoracic Aortic Aneurysm Repair
-
A Phase II, Randomized, Placebo-Controlled, Double-Blind Study of MEDI-507, a Humanized Monoclonal Antibody that Binds to the CD2 Receptor, Administered by Subcutaneous Injection to Adults with Plaque Psoriasis, Protocol IM-CP082
Fellowships, Supported Research, and Other Grants
-
A Phase II, Single Arm Study of Chemoimmunotherapy for the Treatment of Men with Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer (CHAMP)
-
A Phase II, single arm, multicenter trial to determine the efficacy and safety of CTL019 in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia
-
A Phase IIa, Open-label, Multiple Ascending Dose Confirmation Study of the Safety and Tolerability of Intravenous Brincidofovir in Subjects with Adenovirus Infection
-
A Phase IIB multicenter clinical trial of oral SAHA in advanced CTCL
Fellowships, Supported Research, and Other Grants
-
A Phase IIb Randomized, Double-blind, Parallel Group, Placebo- and Active-controlled Study with Double-Blind Extension to Assess the Efficacy and Safety of Vamorolone in Ambulant Boys with Duchenne Muscular Dystrophy (DMD)
-
A Phase IIb, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Crossover, Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults with Attention-Deficit Hyperactivity Disorder (ADHD)
-
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects with Attention-Deficit Hyperactivity Disorder (CEES ADHD)
-
A phase III clinical trial to demonstrate the effectiveness and safety of Liposomal Cyclosporine A (L-CsA) inhalation solution delivered via the PARI Investigational eFlow device plus standard of care v. standard of care of BOS in double lung transpl
-
A phase III clinical trial to demonstrate the effectiveness and safety of Liposomal Cyclosporine A (L-CsA) inhalation solution delivered via the PARI Investigational eFlow device plus standard of care v. standard of care of BOS in single lung transpl
-
A Phase III Clinical Trial to Study the Efficacy & Safety of MK-8931 (SCH900931) in subjects with Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal AD)
-
A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Abiraterone Versus Placebo + Abiraterone as Treatment for Patients with De Novo Metas
-
A Phase III Multi-Center, Randomized, Open-label, Comparative Study to Assess the Efficacy of a Treatment Algorithm to Reduce the Use of Vancomycin in Patients with Intravenous Catheter-Associated Bloodstream Infections (BSI) due to Staphylococci
-
A PHASE III PROSPECTIVE DOUBLE BLIND PLACEBO CONTROLLED RANDOMIZED STUDY
OF ADJUVANT MEDI4736 IN COMPLETELY RESECTED NON-SMALL CELL LUNG CANCER
-
A phase III Randomized Open-Label Multi-Center study of ruxolitinib vs. best available therapy in patients with corticosteroid-refractory chronic graft vs host disease after allogenic stem cell transplantation
-
A Phase III Randomized, Controlled Clinical Trial of Pembrolizumab with or without Platinum-Based Combination Chemotherapy versus Chemotherapy in Subjects with Advanced or Metastatic Urothelial Carcin
-
A Phase III Randomized, Double-Blind Trial to Evaluate the Efficacy of Uproleselan Administered with Chemotherapy versus Chemotherapy Alone
in Patients with Relapsed/Refractory Acute Myeloid Leukemia
-
A Phase III Randomized, Double-Blind, Placebo Controlled Multicrentre Study of Olaparib Maintenance Monotherapy in Patients with BRCA Mutaded Advanced (FIGO Stage III-IV) Ovarian Cancer Following First Line Platinum Based Chemotherapy
-
A Phase III Randomized, Double-Blind, Placebo Controlled, Multi-centre Study of Durvalumab Monotherapy or in Combination with Bevacizumab as Adjuvant Therapy in Patients with Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative
-
A Phase III randomized, double-blind, placebo-controlled study of LEE011 or placebo in combination with tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin for the treatment of premenopausal women with hormone receptor
Research Grant
-
A Phase III Randomized, Double-Blind, Placebo-controlled Trial of Pembrolizumab in Combination with Etoposide/Platinum (Cisplatin or Carboplatin) for the First-line Treatment of Subjects with Extensive Stage Small Cell Lung Cancer
-
A Phase III Randomized, Observer-Blind, Placebo-Controlled Study to Demonstrate the Efficicay of Respiratory Syncytical Virus (RSV) Recombinant F Nanoparticale Vaccine in Prevention of Acute, Symptomatic RSV-Associated Respiratory Disease, and Acute
-
A Phase III Study of 131I Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
-
A Phase III study of pemborlizumab (MK-3475) vs chemotherapy in microstatellite instablility - High (MSI-H) or mismatch repair deficienct (dMMR) stage IV colorectal carcinoma (Keynote - 177)
-
A Phase III, Double-blind, Placebo-controlled, Multi-center International Study of Durvalumab plus Chemotherapy Prior to Surgery Followed by Durvalumab Post-surgery Versus Placebo plus Chemotherapy Prior to Surgery Followed by Placebo Post surgery
-
A phase III, double-blind, randomized, placebo-controlled study to assess the efficacy and safety of selumetinib (AZD624; ARRY-142886) Hyd-Sulfate) in combination with Docetaxel, in patients receiving second line treatment for KRAS Mutation-Positive
-
A Phase III, Multicenter, Rancomized Open-Label Study Evaluating the Efficacy and Safety of MPD3280A (Anti-PD-L1 Antibody)in Combination with Carboplatin + NAB-Paclitaxel for Chemotherapy-Naive Patients with Stage IV NSCLC
-
A PHASE III, MULTICENTER, RANDOMIZED STUDY OF THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF
THE PORT DELIVERY SYSTEM WITH RANIBIZUMAB IN PATIENTS WITH
DIABETIC RETINOPATHY (PAVILION)
-
A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Trial ...
Fellowships, Supported Research, and Other Grants
pages: